Epirubicin hydrochloride injection 50 mg in 25 mL (4)

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

epirubicin hydrochloride, Quantity: 2 mg/mL

Tilgjengelig fra:

Pfizer (Perth) Pty Ltd

Legemiddelform:

Injection, solution

Sammensetning:

Excipient Ingredients: sodium chloride; hydrochloric acid; water for injections

Administreringsrute:

Intravenous, Intravesical, Intraarterial

Enheter i pakken:

25 mL x 1

Resept typen:

(S1) This Schedule is intentionally blank

Indikasjoner:

Indications for Chile: Farmorubicin has the ability to induce useful responses in a broad spectrum of neoplastic diseases, such as carcinoma of breast, malignant lymphomas, sarcoma of the soft tissues, gastric carcinoma, carcinoma of the liver, pancreas, sigmoid rectum, cervicofacial carcinoma, lung carcinoma, ovarian carcinoma and leukemia. High doses of Farmorubicin can be used in the treatment of breast cancer. Positive results have been obtained with Farmorubicin administered intravesically in the treatment of superficial bladder tumors, transitional cells (carcinoma in situ), and in the prophylaxis of recurrences after transurethral resection. Indications for Colombia:Treatment of aeute leukemias, malignant lymphomas, soft tissue sarcoma, gastric cancer, liver cancer, pancreatic cancer, rectosigmoid (bowel) cancer, head and neck cancer, lung cancer, ovarian cancer.

Produkt oppsummering:

Visual Identification: Clear and clean red solution.; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisasjon status:

Listed (Export Only)

Autorisasjon dato:

2018-09-20